Olfr458 Inhibitors
Olfr458, a pivotal member of the olfactory receptor family, plays a central role in mediating the neuronal response to odorant molecules, ultimately leading to the perception of smell. As a G-protein-coupled receptor (GPCR), Olfr458 shares structural features with neurotransmitter and hormone receptors, orchestrating odorant signal transduction through intricate G protein-mediated pathways. The olfactory receptor gene family, with Olfr458 as a significant component, stands as the largest in the genome.
The inhibition of Olfr458 involves a diverse array of chemical interventions targeting various GPCR-associated pathways. Thapsigargin disrupts calcium signaling by inhibiting SERCA pumps, impacting Olfr458 through calcium-dependent processes. Propranolol, a beta-adrenergic receptor antagonist, modifies GPCR-related pathways, potentially inhibiting Olfr458 function. SB203580, a p38 MAP kinase inhibitor, influences MAPK signaling, while Bisindolylmaleimide I targets PKC, affecting olfactory signal transduction. These inhibitors offer valuable insights into potential interventions for Olfr458, shedding light on the intricate mechanisms involved in olfactory signal transduction. The modulation of GPCR-associated pathways by these chemicals provides a nuanced understanding of the potential inhibitory effects on Olfr458 function, contributing to the broader comprehension of olfactory perception at the molecular level.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
SERCA pump inhibitor influencing calcium signaling. Disrupts GPCR-related pathways by modulating intracellular calcium levels, potentially impacting Olfr458 function through calcium-dependent processes in olfactory signal transduction. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
PI3-kinase inhibitor altering intracellular signaling pathways. Indirectly influences olfactory receptor function by disrupting PI3-kinase-dependent processes involved in GPCR-mediated signal transduction. | ||||||
Trametinib | 871700-17-3 | sc-364639 sc-364639A sc-364639B | 5 mg 10 mg 1 g | $114.00 $166.00 $947.00 | 19 | |
MEK inhibitor affecting the MAPK pathway. Alters GPCR-related signal transduction, potentially inhibiting Olfr458 function through downstream modulation of the MAPK cascade. | ||||||
Suramin sodium | 129-46-4 | sc-507209 sc-507209F sc-507209A sc-507209B sc-507209C sc-507209D sc-507209E | 50 mg 100 mg 250 mg 1 g 10 g 25 g 50 g | $152.00 $214.00 $728.00 $2601.00 $10965.00 $21838.00 $41096.00 | 5 | |
Polyanionic compound interfering with GPCR signaling cascades. Acts as a non-specific antagonist, potentially disrupting olfactory receptor protein function through downstream effects on G protein pathways. | ||||||
Propranolol | 525-66-6 | sc-507425 | 100 mg | $180.00 | ||
Beta-adrenergic receptor antagonist impacting GPCR signaling. Modifies intracellular pathways involved in olfactory signal transduction, potentially inhibiting Olfr458 function through modulation of beta-adrenergic receptor-mediated processes. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $458.00 | 61 | |
Intracellular calcium chelator affecting GPCR-mediated signal transduction. Alters calcium-dependent processes, indirectly influencing Olfr458 function by modulating downstream signaling cascades. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
p38 MAP kinase inhibitor impacting MAPK signaling pathways. Modulates cellular responses downstream of GPCR activation, potentially affecting Olfr458 function through the MAPK cascade. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3-kinase inhibitor impacting GPCR-related signaling pathways. Modulates intracellular processes, indirectly influencing Olfr458 function through the disruption of PI3-kinase-dependent cascades. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
PKC inhibitor targeting downstream GPCR signaling. Modifies intracellular pathways involved in olfactory signal transduction, potentially inhibiting Olfr458 function through PKC-mediated processes. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $59.00 $173.00 | 15 | |
Calcium channel blocker influencing GPCR-associated calcium signaling. Alters intracellular calcium levels, potentially inhibiting Olfr458 function through calcium-dependent processes in olfactory signal transduction. | ||||||